The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The compression therapy market has experienced remarkable growth in recent years, ascending from $4 billion in 2023 to an estimated $4.36 billion in 2024, showcasing a substantial Compound Annual Growth Rate (CAGR) of 8.9%. The historic growth is attributed to factors like the aging population, increased prevalence of chronic venous diseases, heightened awareness of the therapeutic benefits of compression, rising cases of diabetes, and expanding indications for compression therapy.

Key Growth Metrics:

• Market Size Growth:From $4 billion (2023) to $4.36 billion (2024) at a CAGR of 8.9%
• Contributing Factors:Aging population, chronic venous diseases, awareness, diabetes-related conditions, expanded indications

A Vision for the Future

The compression therapy market is poised for robust expansion, with a forecasted size of $6.21 billion in 2028, boasting a CAGR of 9.2%. This anticipated growth is propelled by factors such as increased healthcare spending, improved accessibility to compression therapy, a growing geriatric population, rising prevalence of conditions like lymphedema, expansion of applications in sports and fitness, and a surge in the adoption of compression therapy within hospital settings.

Future Trends:

• Wearable and Smart Compression Devices:Integrating technology for enhanced functionality
• Customization of Compression Solutions:Tailoring therapy to individual needs
• Integration in Wound Care Management:Utilizing compression therapy for wound healing
• Emphasis on Patient Comfort:Prioritizing user comfort and compliance
• Collaboration for Improved Outcomes:Partnerships between manufacturers and healthcare providers

Chronic Diseases Driving Market Growth

The increasing prevalence of chronic diseases emerges as a key driver propelling the growth of the compression therapy market. Chronic diseases, characterized by long-term health conditions, often necessitate the use of compression therapy to address symptoms such as diabetes, edema, ulcers, and circulatory issues. Notably, the International Diabetes Federation predicts a global diabetic population reaching 537 million in 2021, escalating to 643 million in 2030 and 783 million in 2045, accentuating the need for effective compression therapy.

Notable Statistic:

• In 2021, the International Diabetes Federation estimated 537 million people globally with diabetes.

Innovative Product Developments

Major players in the compression therapy market are at the forefront of innovation, introducing products such as wearable compression systems to cater to a broader customer base and boost revenue. An exemplary case is Koya Medical Inc., which launched the Dayspring active compression system in April 2022. This dynamic system, catering to lymphedema and venous diseases in the lower extremities, represents a groundbreaking, FDA-approved non-pneumatic active compression treatment. It combines a comfortable, breathable mesh garment with intelligent, rechargeable controllers featuring Bluetooth capabilities and companion software for personalized treatment and progress assessment.

Read More On The Compression Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/compression-therapy-global-market-report

Noteworthy Product Launch:

• Koya Medical Inc.’s Dayspring active compression system

Strategic Acquisitions Shaping the Market Landscape

In a strategic move in March 2021, Direct Healthcare Group (DHG) Ltd., a UK-based medical device company, acquired Talley Group Ltd., a US-based compression therapy provider. This acquisition enhances DHG’s pressure ulcer prevention portfolio and facilitates entry into the Negative Pressure Wound Therapy (NPWT) and Intermittent Pneumatic Compression (IPC) therapy markets. The synergy between DHG and Talley’s expertise ensures a comprehensive product portfolio for enhanced health outcomes.

Acquisition Highlights:

• Acquirer:Direct Healthcare Group (DHG) Ltd.
• Acquired:Talley Group Ltd.
• Objective:Expanding pressure ulcer prevention portfolio, entering NPWT and IPC therapy markets

Market Segmentation

The compression therapy market is segmented based on products, techniques, and applications.

1. Product Segmentation:
   • Compression Pumps
   • Compression Stockings
   • Compression Bandages
   • Compression Tapes
2. Technique Segmentation:
   • Static Compression Therapy
   • Dynamic Compression Therapy
3. Application Segmentation:
   • Varicose Vein Treatment
   • Deep Vein Thrombosis Treatment
   • Lymphedema Treatment
   • Leg Ulcer Treatment
   • Other Applications

Regional Dominance

North America asserted itself as the largest region in the compression therapy market in 2023, underlining the region’s proactive approach toward adopting and advancing compression therapy solutions.

Regional Insights:

• Largest Market:North America (2023)

In conclusion, the compression therapy market’s trajectory is marked by innovation, strategic collaborations, and a commitment to addressing the diverse needs of individuals with chronic conditions. As the market continues to evolve, the emphasis on technological integration, personalized solutions, and collaborative efforts between manufacturers and healthcare providers is set to redefine the landscape of compression therapy, promoting enhanced patient outcomes and well-being.

Request for A Sample Of The Global Compression Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5238&type=smp